Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Vilstrup, P. Amodio, J. Bajaj, J. Córdoba, P. Ferenci, K. Mullen, K. Weissenborn, P. Wong (2014)
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the LiverHepatology, 60
P. Caraceni, O. Riggio, P. Angeli, C. Alessandria, S. Neri, F. Foschi, F. Levantesi, A. Airoldi, S. Boccia, G. Svegliati-Baroni, S. Fagiuoli, R. Romanelli, R. Cozzolongo, V. Marco, V. Sangiovanni, F. Morisco, P. Toniutto, A. Tortora, R. Marco, M. Angelico, I. Cacciola, G. Elia, A. Federico, S. Massironi, R. Guarisco, A. Galioto, G. Ballardini, M. Rendina, S. Nardelli, S. Piano, C. Elia, L. Prestianni, F. Cappa, L. Cesarini, L. Simone, Chiara Pasquale, M. Cavallin, A. Andrealli, F. Fidone, M. Ruggeri, A. Roncadori, M. Baldassarre, M. Tufoni, G. Zaccherini, M. Bernardi, M. Domenicali, F. Giannone, M. Merli, S. Gioia, S. Fasolato, A. Sticca, D. Campion, A. Risso, G. Saracco, D. Maiorca, A. Rizzotto, A. Lanzi, Elga Neri, Anna Visani, A. Mastroianni, A. Alberti, C. Mazzarelli, M. Vangeli, M. Marzioni, F. Capretti, A. Kostandini, G. Magini, M. Colpani, G. Laffi, T. Gabbani, M. Marsico, M. Zappimbulso, J. Petruzzi, V. Calvaruso, G. Parrella, N. Caporaso, F. Auriemma, M. Guarino, F. Pugliese, A. Gasbarrini, Pietro Leo, F. Leonardis, A. Pecchioli, P. Rossi, G. Raimondo, E. Negri, M. Dallio, C. Loguercio, D. Conte, N. Celli, R. Bringiotti, N. Castellaneta, F. Salerno (2018)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trialThe Lancet, 391
M. Simón-Talero, R. García-Martínez, M. Torrens, S. Augustin, S. Gómez, G. Pereira, M. Guevara, P. Ginés, G. Soriano, E. Román, J. Sánchez-Delgado, R. Ferrer, J. Nieto, P. Sunyé, Inma Fuentes, R. Esteban, J. Córdoba (2013)
Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.Journal of hepatology, 59 6
(2013)
RELIEF study group et
V. Arora, R. Vijayaraghavan, R. Maiwall, Amrish Sahney, S. Thomas, R. Ali, P. Jain, G. Kumar, S. Sarin (2019)
Paracentesis‐Induced Circulatory Dysfunction With Modest‐Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute‐on‐Chronic Liver FailureHepatology, 72
D. Shawcross, Gavin Wright, S. Damink, R. Jalan (2007)
Role of ammonia and inflammation in minimal hepatic encephalopathyMetabolic Brain Disease, 22
Ming Luo, Jianyang Guo, Wu-kui Cao (2015)
Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.World journal of gastroenterology, 21 41
G. Bianchi, M. Giovagnoli, A. Sasdelli, G. Marchesini (2012)
Hepatic encephalopathy and health-related quality of life.Clinics in liver disease, 16 1
Tai‐An Chen, Y. Tsao, Angela Chen, G. Lo, Chiun‐ku Lin, Hsien‐Chung Yu, Lung-Chih Cheng, P. Hsu, W. Tsai (2009)
Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitisScandinavian Journal of Gastroenterology, 44
P. Ferenci, A. Lockwood, K. Mullen, R. Tarter, K. Weissenborn, A. Blei (2002)
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998Hepatology, 35
Javier Fernández, J. Clària, A. Amorós, F. Aguilar, M. Castro, M. Casulleras, J. Acevedo, Marta Duran-Güell, L. Núñez, M. Costa, M. Torres, R. Horrillo, L. Ruíz‐del‐Árbol, C. Villanueva, V. Prado, M. Arteaga, J. Trebicka, P. Angeli, M. Merli, C. Alessandria, N. Aagaard, G. Soriano, F. Durand, A. Gerbes, T. Gustot, T. Welzel, F. Salerno, R. Bañares, V. Vargas, A. Albillos, Aníbal Silva, M. Morales-Ruiz, Juan García‐Pagán, M. Pavesi, R. Jalan, M. Bernardi, R. Moreau, A. Páez, V. Arroyo (2019)
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.Gastroenterology, 157 1
D. Aldridge, E. Tranah, D. Shawcross (2015)
Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.Journal of clinical and experimental hepatology, 5 Suppl 1
P. Ginés, V. Arroyo, Enriqueta Quintero, R. Planas, F. Bory, J. Cabrera, A. Rimola, J. Viver, J. Camps, W. Jiménez, R. Mastai, J. Gaya, J. Rodés (1987)
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.Gastroenterology, 93 2
J. Bajaj, A. Fagan, E. Gavis, Z. Kassam, M. Sikaroodi, P. Gillevet (2019)
Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.Gastroenterology, 156 6
M. Iadevaia, A. Prete, C. Cesaro, L. Gaeta, C. Zulli, C. Loguercio (2011)
Rifaximin in the treatment of hepatic encephalopathyHepatic Medicine : Evidence and Research, 3
S. Mitzner (2011)
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).Annals of hepatology, 10 Suppl 1
E. Solà, C. Solé, M. Simón-Talero, Marta Martín‐Llahí, J. Castellote, R. García-Martínez, Rebeca Moreira, M. Torrens, F. Márquez, N. Fabrellas, Glòria Prada, P. Huelin, Eva Benaiges, M. Ventura, M. Manríquez, A. Nazar, X. Ariza, P. Suñé, I. Graupera, E. Pose, J. Colmenero, M. Pavesi, M. Guevara, M. Navasa, X. Xiol, J. Córdoba, V. Vargas, P. Ginés (2018)
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.Journal of hepatology, 69 6
R. García-Martínez, P. Caraceni, M. Bernardi, P. Ginés, V. Arroyo, R. Jalan (2013)
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complicationsHepatology, 58
S. Montagnese, M. Lauridsen, H. Vilstrup, L. Zarantonello, G. Lakner, S. Fitilev, I. Zupanets, I. Kozlova, E. Bunkova, K. Tomasiewicz, J. Berglund, F. Rorsman, H. Hagström, S. Kechagias, C. Ocklind, Joseph Mauney, Fredrik Thunarf, Masoud Mokhatarani, T. Bäckström, M. Doverskog, Lars-Erik Lins, M. Månsson, P. Samuelson, D. Nilsson, M. Schalling, M. Johansson, E. Arlander, B. Scharschmidt (2021)
A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy.Journal of hepatology
A. Bohra, T. Worland, Samuel Hui, R. Terbah, A. Farrell, Marcus Robertson (2020)
Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of careWorld Journal of Gastroenterology, 26
R. Bañares, F. Nevens, F. Larsen, R. Jalan, A. Albillos, M. Dollinger, F. Saliba, T. Sauerbruch, S. Klammt, J. Ockenga, A. Parés, J. Wendon, T. Brünnler, L. Kramer, P. Mathurin, M. Mata, A. Gasbarrini, B. Müllhaupt, A. Wilmer, W. Laleman, M. Eefsen, S. Sen, A. Zipprich, T. Tenorio, M. Pavesi, H. Schmidt, S. Mitzner, Roger Williams, V. Arroyo (2013)
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trialHepatology, 57
B. Sharma, Jatinderpal Singh, S. Srivastava, Alok Sangam, A. Mantri, N. Trehanpati, S. Sarin (2017)
Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathyJournal of Gastroenterology and Hepatology, 32
O. Riggio, S. Nardelli, Chiara Pasquale, I. Pentassuglio, S. Gioia, E. Onori, Camilla Frieri, F. Salvatori, M. Merli (2015)
No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shuntMetabolic Brain Disease, 31
A. Jayakumar, M. Norenberg (2018)
Hyperammonemia in Hepatic Encephalopathy.Journal of clinical and experimental hepatology, 8 3
E. Strauss, R. Tramote, Silva Ep, W. Caly, Nadim Honain, M. Ra, de Mf (1992)
Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.Hepato-gastroenterology, 39 6
L. Gluud, H. Vilstrup, M. Morgan (2016)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.The Cochrane database of systematic reviews, 4
M. Pascoli, S. Fasolato, S. Piano, M. Bolognesi, P. Angeli (2018)
Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascitesLiver International, 39
R. Butterworth (2019)
Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysisMetabolic Brain Disease, 35
Kavish Patidar, J. Bajaj (2013)
Antibiotics for the treatment of hepatic encephalopathyMetabolic Brain Disease, 28
R. Jalan, D. Kapoor (2004)
Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid.Clinical science, 106 5
Kok Teh, J. Loo, Y. Tam, Y. Wong (2021)
Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
NM Bass (2010)
1071N Engl J Med, 25
B. Görg, N. Qvartskhava, H. Bidmon, N. Palomero-Gallagher, G. Kircheis, K. Zilles, D. Häussinger (2010)
Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathyHepatology, 52
R. Planas, P. Ginés, V. Arroyo, J. Llach, Julià Panés, V. Vargas, J. Salmerón, A. Ginès, C. Toledo, A. Rimola, W. Jiménez, M. Asbert, M. Gassull, J. Rodés (1990)
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.Gastroenterology, 99 6
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Hepatic encephalopathy (HE) is a common complication that occurs in 16–21% of end-stage cirrhosis patients. Emerging evidence suggests that systemic inflammation and oxidative stress may play a role in the development of HE. Recent understanding on the anti-inflammatory properties of human albumin has led to growing interest of using human albumin for the treatment and prevention of HE among decompensated patients. In this review, we aim to discuss the current evidence and controversies of using human albumin for the treatment and prevention of HE in advanced cirrhosis patients.
Metabolic Brain Disease – Springer Journals
Published: Jun 1, 2023
Keywords: Albumins; Hepatic encephalopathy; Liver cirrhosis; Mortality
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.